写意报告 | 当过冬可能成为常态，Biotech人才内驱力如何激发？
本文系吕筱在“第四届全球生物医药前沿技术大会”上做报告整理。
Time：
2023-08-24 09:15
Author：
xieyijun
Seagen再为辉瑞赢下一局？ADC联合疗法达到III期临床终点
为寻求更“合拍”的ADC搭档，Enhertu将是Tukysa的下一个目标
Time：
2023-08-19 09:24
Author：
xieyijun
Recommended content
WCLC 2026 | Hansun "Blows the Roof Off", the New King of B7-H3 ADC is About to be Crowned
It's time for Chinese innovative drugs to redefine the standards.
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务